Fabrication of Curcumin-loaded Olaminosomes for Intracorneal Permeation Enhancement

Background: Curcumin, a polyphenolic compound obtained from Curcuma longa , demonstrates potent anti-inflammatory, antioxidant, and immunomodulatory properties, making it a promising candidate for treating ocular inflammatory conditions. However, it faces significant challenges, including low bioavailability, rapid metabolic degradation, poor aqueous solubility, and inadequate corneal penetration. Aim: To formulate and optimise drug-loaded olaminosomes encapsulating Curcumin for enhanced ocular delivery. Methods: Preformulation studies were conducted, including solubility analysis in various solvents and drug excipient compatibility studies using Fourier-Transform Infrared Spectroscopy (FTIR). Olaminosomes, a novel nanovesicular carrier, were prepared using the ethanol injection method, incorporating octadecyl amine, span 80, and oleic acid as lipid, nonionic surfactant, and edge activator to enhance drug entrapment and corneal penetration. Results: The formulation exhibited a vesicle size of 430 nm, a polydispersity index (PDI) of 0.41, an entrapment efficiency of 29.6%, and ex vivo corneal permeation of 40% Curcumin and 60% olaminosomes over 2 hours. Conclusion: These findings underscore the potential of olaminosomes as a promising nanovesicular platform for sustained and targeted ocular drug delivery. Major Findings: Curcumin-loaded olaminosomes were successfully developed with a vesicle size of 430 nm, PDI of 0.41, and entrapment efficiency of 29.6%. The formulation significantly enhanced ex vivo corneal permeation (60%) compared to free Curcumin (40%).

View article page

Download PDF